EAO congress 2025: Blending science and masterpieces

Dr Mahou, what inspired the “Art of Regeneration” campaign?
Our inspiration comes from clinicians who dedicate their surgical proficiency to crafting smiles every day. Although implant procedures are seen primarily as technical interventions to restore function, they affect patients’ self-confidence and social lives profoundly. In that sense, implant dentistry fits the definition of art: the application of creative skill to produce works appreciated for their beauty or emotional power. This campaign reflects that idea and highlights the artistry behind our regenerative biomaterials by presenting them in an artful, engaging manner.

How is BioHorizons Camlog differentiating its biomaterials in an increasingly competitive market?
Our ability to offer a portfolio of complementary products sets us apart. While some providers rely on single solutions and have minimal diversification, we believe that every clinical case is unique and that no one biomaterial can fulfil all treatment requirements. That is why we have developed a comprehensive range of products, helping dental professionals tailor patient-centric treatments and closely meet individual clinical needs.

How did you select the products highlighted in the “Art of Regeneration” campaign, and how do they complement each other and relate to the European market?
Each product represents a broader product line, showcasing the completeness of our portfolio. The first is MinerOss A, which represents our bone substitutes. It is a mineralised collagen of human origin with preserved structure and composition. Thanks to its rapid and complete remodelling into the surrounding bone, it enables early re-entry and offers a predictable alternative to autologous bone.^1, 2 MinerOss A was matched with Claude Monet, whose work mirrors the natural character and subtle performance of this bone grafting material. Our bone substitute portfolio also includes xenografts (bovine or porcine) and fully synthetic substitutes (alloplastic materials).

Striate+ is the second, representing our barrier membranes. It is a resorbable collagen membrane derived from porcine mesentery and produced without chemical cross-linking. It offers excellent handling, optimal tissue integration and strong osteoconductive properties, favouring osteogenesis and enabling mature bone formation at an earlier stage.³ Striate+ was paired with Andy Warhol, symbolising the bold, innovative spirit of the pop art movement, which reflects the contemporary nature of the membrane. In addition to Striate+, the portfolio includes membranes from human or porcine pericardium, chemically treated membranes with varying degrees of cross-linking and fully synthetic PTFE membranes.

Finally, NovoMatrix represents our soft-tissue regeneration solutions. It is an acellular dermal matrix that, once transplanted, is repopulated by the patient’s own cells and remodelled into functional soft tissue within weeks. NovoMatrix offers a ready alternative to autologous connective tissue grafts, eliminating the need for a donor site and significantly reducing surgical time. NovoMatrix was paired with Vincent Van Gogh, representing the vivid colours and emotional intensity of post-Impressionism—qualities that mirror the aesthetic excellence achieved with this product.

What trends in biomaterials do you see shaping the future of implant dentistry?
There is growing interest in using hyaluronic acid derivatives in regenerative procedures to improve vascularisation of bone grafts and stimulate the migration and differentiation of osteogenic cells. To remain at the forefront in this regard, BioHorizons Camlog recently launched CeraOss HYA, a two-in-one combination of bovine bone and hyaluronic acid. The bovine bone provides an osteoconductive scaffold and maintains volume stability, while the hyaluronic acid forms the bone particles into a malleable mass known as sticky bone, improving handling and application to bone defects.

Hyaluronic acid has been associated with enhanced angiogenesis, increased cell activity and improved bone regeneration after peri-implantitis reconstructive surgery.⁴ The hyaluronic acid in CeraOss HYA is bio-technologically produced by fermentation, and it is fully biocompatible, non-immunogenic and naturally resorbed through enzymatic degradation within two weeks after implantation.

In response to the positive feedback on CeraOss HYA, BioHorizons Camlog is working on expanding this approach to other bone substitutes. Dental professionals can visit www.biohorizonscamlog.com to stay updated on the latest product launches.